COVID-19 Vaccination in Patients with Severe Asthma on Biologic Treatment: Safety, Tolerability, and Impact on Disease Control

COVID-19 Vaccination in Patients with Severe Asthma on Biologic Treatment: Safety, Tolerability, and Impact on Disease Control

Background: COVID-19 vaccination has been recommended for severe asthmatics. We aimed to evaluate the safety, tolerability, and impact on disease control and patient’s quality of life of the mRNA SARS-CoV-2/COVID-19 vaccine in severe asthma patients regarding biologic treatment. Methods: Severe asth...

Full description

Bibliographic Details
Main Authors: Marco Caminati, Gabriella Guarnieri, Veronica Batani, Elena Scarpieri, Anita Finocchiaro, Fulvia Chieco-Bianchi, Gianenrico Senna, Andrea Vianello
Format: Article
Language:English
Published: MDPI AG 2021-08-01
Series:Vaccines
Subjects:
Pfizer mRNA SARS-CoV-2/COVID 19 vaccine
severe asthma
biologics
safety
tolerability
quality of life
Online Access:https://www.mdpi.com/2076-393X/9/8/853

Internet

https://www.mdpi.com/2076-393X/9/8/853

Similar Items